SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001640455-17-000057
Filing Date
2017-12-21
Accepted
2017-12-21 16:59:09
Documents
2
Period of Report
2017-12-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_151389353413349.html 3  
1 FORM 3 wf-form3_151389353413349.xml 3 2978
2 EXHIBIT 24 - COLE LIMITED POWER OF ATTORNEY ex-24.htm EX-24 4372
  Complete submission text file 0001640455-17-000057.txt   8692
Mailing Address C/O ARIAD PHARMACEUTICALS, INC 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Cole Hugh M (Reporting) CIK: 0001604646 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37998 | Film No.: 171270056

Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Issuer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)